Author name: Leonardo Arias

El futuro de los osos polares se derrite, literalmente, bajo sus patas. En las últimas décadas, el cambio climático ha transformado el Ártico a un ritmo sin precedentes, poniendo en riesgo la supervivencia de una de las especies más emblemáticas del planeta. …

“Comprender los algoritmos”, escrito por Aditya Y. Bhargava, es un libro que se ha ganado un lugar especial entre los programadores. Ideado como una obra de divulgación técnica sobre algoritmos y estructuras de datos orientado a programadores principiantes o autodidactas, f …

Recruiters can play a significant role in biopharma professionals getting hired, especially in an employer-driven job market. However, when working with them, candidates need to avoid making six key mistakes, from waiting too long to ask for help to prematurely contacting hiring companies.

Among those who connected salary increases to swapping out employers, 75% saw pay rise by at least 6%, and the most often cited increase was 10%, according to the just-released BioSpace salary report.

Looking for a clinical job? Check out the BioSpace list of 11 companies hiring life sciences professionals like you.

As Congress debates renewing the Act for ALS, it must prepare for the coming era of precision ALS medicine by prioritizing early-stage research to more quickly bring effective treatments to the market.

Every biopharma R&D and investment decision could be guided by connected intelligence. Join us to hear firsthand how agentic workflows and enterprise-scale data are helping drug developers move faster from molecule to market with greater confidence.

MiniMed Flex is a smartphone-controlled insulin pump about half the size of MiniMed’s previous device. It’s the company’s first launch since separating from Medtronic in early March.

The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition from the Federal Trade Commission.

Constructing the cGMP facility will increase availability of actinium-225, a nuclear material central to radiopharmaceutical programs at AstraZeneca, Bristol Myers Squibb, Eli Lilly and Novartis.